Oppenheimer Reiterates Perform Rating on Gentiva Health Services on FY2013 Outlook
In a report published Wednesday, Oppenheimer analyst Michael Wiederhorn reiterated a Perform rating on Gentiva Health Services (NASDAQ: GTIV).
In the report, Wiederhorn noted, “Gentiva issued its FY2013 outlook, which includes EPS of $0.90-$1.10, compared to our estimate of $1.15 and Street consensus of $1.26. The guidance includes a $0.60 impact from the Medicare sequestration, well above the impact included in our estimate. As a result of the outlook, we are reducing our FY2013-14 estimates to $0.98 and $0.99, from $1.15 and $1.17, respectively.”
Gentiva Health Services closed on Tuesday at $12.62.
Latest Ratings for GTIV
|Aug 2014||Credit Suisse||Maintains||Underperform|
|Jul 2014||Deutsche Bank||Maintains||Hold|
|Jun 2014||CRT Capital||Downgrades||Buy||Fair Value|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.